You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新產業(300832.SZ):擬將募集資金約2.61億元用於“新產業生物研發大廈”項目
格隆匯 06-03 20:26

格隆匯6月3日丨新產業(300832.SZ)公佈,為提高募集資金使用效率,提升公司競爭力和盈利能力,公司決定將《首次公開發行股票並在創業板上市招股説明書》中披露的“新產業生物海外拓展項目”中的未實施部分終止,終止項目後剩餘未投入募集資金為約2.61億元(不含利息及賬户管理費收支)。同時,公司擬將募集資金約2.61億元用於“新產業生物研發大廈”項目,擬變更用途的募集資金佔總籌資額的21.69%。

此次擬變更“新產業生物海外拓展項目”的主要原因是鑑於當前新冠肺炎疫情在境外還未得到有效控制,難以預測未來新冠疫情對公司海外拓展項目實施的影響,因此為提高募集資金使用的合理性和有效性,增強公司整體盈利能力,公司計劃對尚未使用的募集資金約2.61億元做投資項目變更。

此次募集資金投資項目變更後,公司擬投資於“新產業生物研發大廈”。該項目實施主體為深圳市新產業生物醫學工程股份有限公司,項目位於深圳市坪山區錦繡東路與臨鬆路交匯處西南角。該項目將新建新產業生物研發大廈,宗地總用地面積為22006平方米,建築面積88000平方米,主要包括儀器研發中心、儀器生產車間和配套試劑生產車間,並完成其主體建設、裝修等。項目總投資為2.98億元,建設期為36個月,達產期為36個月,項目達產後,將形成全自動化學發光系列儀器5000台、配套診斷試劑500萬盒的生產能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account